Overview
TMO market data
Price History
TMO price chart · 1M
- O
- 684.91
- H
- 693.21
- L
- 654.53
- C
- 656.87
- Vol
- 161,304.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $684.91
- Previous Close
- $676.30
- Day High
- $693.21
- Day Low
- $654.53
- 52 Week High
- $693.21
- 52 Week Low
- $435.20
- 7 Day Return
- -3.40%
- 30 Day Return
- +8.99%
- 90 Day Return
- +28.91%
- 1 Year Return
- +21.15%
- Daily Notional Volume
- $106M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 35.09 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $17.73 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.86 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.3% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 15.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $435.27 – $683.63 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $244.4B · P/B 4.08 · P/S 5.28.
Company News
10 captured
Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple SclerosisGlobenewswire Inc ·
Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and AutomationGlobenewswire Inc ·
EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug TrialBenzinga ·
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGRGlobenewswire Inc ·
Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion OpportunityGlobenewswire Inc ·